In this study we further embarked on the potential anti-fibrotic role of ACKR3 agonism by studying the effect of this previously described ACKR3-targeting small molecule agonist [21] in preclinical mouse models of lung and liver fibrosis. The gene discussed is ACKR3; the disease is Hepatic fibrosis.